3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
11
Brain Neoplasms
11
Gliosarcoma
9
Neuroblastoma
5
Astrocytoma
5
Oligodendroglioma
4
Glioma
4
Carcinoma, Renal Cell
4
Sarcoma, Ewing
3
Sarcoma
3
Rhabdomyosarcoma
3
Rhabdoid Tumor
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Wilms Tumor
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neurofibromatosis 2
2
Neurofibromatosis 1
2
Neoplasms
2
Melanoma
2
Medulloblastoma
2
Ependymoma
2
Carcinoma, Hepatocellular
2
Vestibulocochlear Nerve Diseases
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Sirolimus
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Otorhinolaryngologic Diseases
×
Sirolimus
×
CNS
×
Clear all
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled